AstraZeneca expects updated COVID-19 vaccine by autumn
3 years, 10 months ago

AstraZeneca expects updated COVID-19 vaccine by autumn

Associated Press  

LONDON — AstraZeneca said Thursday it expects to have a new version of its COVID-19 vaccine ready for use by this autumn as drugmakers respond to concerns about emerging variants of the disease that may be more transmissible or resistant to existing vaccines. The comments came as CEO Pascal Soriot defended the company’s efforts to develop and ramp up production of the shot amid criticism from the European Union and a preliminary study that raised concerns about the vaccine’s ability to combat a variant of COVID-19 first discovered in South Africa. While rollout of the vaccine hasn’t been perfect, regulators in a number of countries have found the vaccine to be safe and effective, and AstraZeneca will produce 100 million doses this month, Soriot said. “One hundred million doses in February means 100 million vaccinations, which means hundreds of thousands of severe infections that are avoided, and it also means thousands of deaths that are avoided,” Soriot said.

Vaccine Variant Astrazeneca Soriot  million  shot  vaccine  regulators  updated  expects  covid19  variants  soriot  astrazeneca  variant  study  vaccines  autumn

History of this topic

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
7 months, 1 week ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?
7 months, 2 weeks ago

AstraZeneca withdraws Covishield pointing to low demand, but did rare side effects also play a role?

The Hindu  

Published : May 09, 2024 13:21 IST - 3 MINS READ The pharmaceutical giant AstraZeneca has reportedly withdrawn its COVID-19 vaccine Vaxzevria, also known as Covishield, worldwide, citing commercial reasons for the decision. Vaxzevria saved millions of lives AstraZeneca, who developed the vaccine with Oxford University, said it was “incredibly proud of the role Vaxzevria played in ending the global …

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
7 months, 2 weeks ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
7 months, 2 weeks ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots
7 months, 2 weeks ago

AstraZeneca withdraws Covid vaccine worldwide after admitting it can cause rare blood clots

The Independent  

The best of Voices delivered to your inbox every week - from controversial columns to expert analysis Sign up for our free weekly Voices newsletter for expert opinion and columns Sign up to our free weekly Voices newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, …

AstraZeneca pulls its COVID-19 vaccine from the European market
7 months, 2 weeks ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
7 months, 2 weeks ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

As AstraZeneca announces vaccine withdrawal, Serum Institute says stopped Covishield in 2021
7 months, 2 weeks ago

As AstraZeneca announces vaccine withdrawal, Serum Institute says stopped Covishield in 2021

New Indian Express  

NEW DELHI: Days after AstraZeneca admitted for the first time in court documents that their Covid-19 vaccine can cause a rare and dangerous side effect, the British pharma giant announced that they are withdrawing it globally. In its statement, AstraZeneca said, "As multiple, variant COVID-19 vaccines have since been developed, there is a surplus of available updated vaccines. According to …

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers
7 months, 2 weeks ago

AstraZeneca removes its Covid vaccine worldwide after rare and dangerous side effect linked to 80 deaths in Britain was admitted in court papers

Daily Mail  

AstraZeneca is removing its Covid vaccine worldwide, months after the pharmaceutical giant admitted that it can cause a rare and dangerous side effect. The vaccine, once heralded as a 'triumph for British science', has come under intense scrutiny in recent months for a very rare side effect causing blood clots and low blood platelet counts. The AstraZeneca jab was the …

COVID-19 vaccines: Much ado about known unknowns
7 months, 2 weeks ago

COVID-19 vaccines: Much ado about known unknowns

The Hindu  

There are things we know that we don’t know. This risk was identified and flagged back in 2021; packaging was modified to insert information associated with the side effects; even the WHO wrote about it first in May 2021 and then in 2023.Read Bindu Shajan Perapaddan’s report on the rare vaccine side-effect is “no secret” and they are “well aware …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
7 months, 3 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

AstraZeneca admits its Covishield vaccine may lead to rare side effect
7 months, 3 weeks ago

AstraZeneca admits its Covishield vaccine may lead to rare side effect

New Indian Express  

As reported by The Telegraph, although AstraZeneca is disputing the allegations, it acknowledged in a legal filing submitted to the High Court in February that the vaccine "can, in very rare instances, lead to TTS." AstraZeneca, in a May 2023 response to Scott's lawyers, contested any direct link between the vaccine and TTS, stating they do not accept such a …

AstraZeneca admits in court that its Covid vaccine can cause rare side-effect ‘TTS’, what is it?
7 months, 3 weeks ago

AstraZeneca admits in court that its Covid vaccine can cause rare side-effect ‘TTS’, what is it?

Hindustan Times  

Pharmaceutical giant AstraZeneca has accepted for the first time that its Covid vaccine “can, in very rare cases, cause TTS”. {{^usCountry}} {{/usCountry}} AstraZeneca has been fighting a class action lawsuit that alleges its Covid vaccine, which was developed with the help of University of Oxford, has led to several deaths and serious injury. {{^userSubscribed}} {{/userSubscribed}} {{^userSubscribed}} {{/userSubscribed}} Responding to Scott's …

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court
7 months, 3 weeks ago

UK-Based AstraZeneca Acknowledges Rare Health Risk Of Its Covid Vaccine In Court

News 18  

UK-based AstraZeneca has acknowledged in court that its Covid vaccine can cause a rare blood clotting condition, British media reports said on Monday. The admission comes amid legal proceedings triggered by claims that the vaccine led to serious health complications, The Daily Mail reported. In a legal document submitted to a UK court in February, the Cambridge-based company conceded that …

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab
1 year ago

AstraZeneca strikes £880m deal to buy US vaccine maker amid questions over Covid jab

The Telegraph  

Iskra Reic, executive vice president of vaccines and immune therapies at AstraZeneca, said: “This aligns with our strategy to deliver a portfolio of therapies to address high unmet needs in infectious diseases, and our ambition to protect the most vulnerable patients who have high risk of severe outcomes.” Shares in AstraZeneca rose 1.3pc in afternoon trade on news of the …

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know
1 year, 1 month ago

How safe is AstraZeneca's Covid jab? What rare complications can it cause? Who is taking legal action against the pharma giant? All you need to know

Daily Mail  

As Brits take AstraZeneca to court we recount what happened with the Covid jab AstraZeneca's Covid vaccine undoubtedly saved millions of lives. AstraZeneca's Covid jab timeline January 2020: Oxford University scientists start working on a Covid vaccine after the World Health Organization declares the spread of the virus a 'Public Health Emergency of International Concern' March 2020: Then Prime Minister …

Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case
1 year, 1 month ago

Oxford AstraZeneca Covid jab was ‘defective’, claims landmark legal case

The Telegraph  

As many as 80 claimants could lodge legal cases with the High Court by the end of the year in a class action that threatens to undermine faith in the rollout of the AstraZeneca vaccine that was developed jointly with Oxford University. In Mr Scott’s claim, his lawyers argue that he suffered “personal injuries and consequential losses arising out of …

The victims of AstraZeneca's vaccine
1 year, 7 months ago

The victims of AstraZeneca's vaccine

Daily Mail  

Jab complications were rare but the massive rollout saw dozens of Brits killed Covid vaccines are estimated to have saved millions of lives, by both protecting people from the virus and helping end the paralysing series of lockdowns. An inquest heard he was told there was no Pfizer jab in stock and was given out-of-date information in relation to blood …

India restarts Covid vaccine production as new infections soar 30% in one day
1 year, 8 months ago

India restarts Covid vaccine production as new infections soar 30% in one day

The Independent  

India is ramping up its vaccine production following a rapid surge in Covid-19 cases driven by a new subvariant dubbed Arcturus. The country recorded 10,158 news Covid cases on Thursday, a 30 per cent surge in one day, according to the federal health ministry data. The company stopped manufacturing Covishield in December 2021 due to dwindling demand and a low …

AstraZeneca expects ‘minimal’ sales of Covid vaccine this year
1 year, 10 months ago

AstraZeneca expects ‘minimal’ sales of Covid vaccine this year

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. A year earlier the business sold 1.8 billion US …

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella
1 year, 10 months ago

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella

India TV News  

COVID-19 vaccine : Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday. "We dispatched three lakh doses of the world's first intranasal COVID-19 vaccine to some hospitals two days ago," Ella said. Establishing the UW-Madison Global One Health Centre holds great significance as …

Study confirms AstraZeneca jab’s higher risk of very rare clot
2 years, 1 month ago

Study confirms AstraZeneca jab’s higher risk of very rare clot

The Hindu  

AstraZeneca's Covid vaccine has been linked to a 30% higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that -- in a tiny number of cases -- thrombosis with thrombocytopenia syndrome can be a possible side effect …

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study
2 years, 1 month ago

AstraZeneca Covid Jab Linked to 30% Higher Risk of Very Rare Blood Clot: Study

News 18  

AstraZeneca’s Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. Several countries have already altered their advice after previous research indicated that — in a tiny number of cases — thrombosis with thrombocytopenia syndrome can be a possible side effect …

High Hopes for Nasal Covid Vaccines Despite 'Disappointing' AstraZeneca Trial
2 years, 2 months ago

High Hopes for Nasal Covid Vaccines Despite 'Disappointing' AstraZeneca Trial

News 18  

Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite “disappointing” recent trial results for an AstraZeneca spray, experts say. Eric Tartour, an immunologist at the European Hospital Georges Pompidou in Paris, said that while the AstraZeneca results “are indeed disappointing”, he did not think the news “dampens hope for nasal vaccines”. However, the vaccine …

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 2 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18  

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

AstraZeneca and Pfizer Vaccines Saved Over 1.2 Crore Lives in First Year: Study
2 years, 5 months ago

AstraZeneca and Pfizer Vaccines Saved Over 1.2 Crore Lives in First Year: Study

News 18  

The AstraZeneca and Pfizer COVID-19 vaccines saved over 1.2 crores lives, while India's indigenous Covaxin averted over 3.7 lakh deaths in the first year of the global immunisation campaign, according to a modelling study. Last month, a study on excess deaths from 185 countries and territories by the Imperial College London, UK, calculated that COVID-19 vaccines saved around 2 crore …

FDA advisers recommend updating COVID booster shots for fall
2 years, 5 months ago

FDA advisers recommend updating COVID booster shots for fall

Associated Press  

At least some U.S. adults may get updated COVID-19 shots this fall, as government advisers voted Tuesday that it’s time to tweak booster doses to better match the most recent virus variants. Their combination shots, what scientists call “bivalent” vaccines, substantially boosted levels of antibodies capable of fighting that variant, more than simply giving another dose of today’s vaccine. Marks …

FDA grapples with whether to modify COVID vaccine for fall
2 years, 5 months ago

FDA grapples with whether to modify COVID vaccine for fall

LA Times  

The Food and Drug Administration will debate Tuesday whether it’s time to update COVID vaccine formulas. “This is science at its toughest,” said FDA vaccine chief Dr. Peter Marks, adding that a final decision is expected within days of the advisory panel’s recommendation. In an analysis prepared for Tuesday’s meeting, FDA officials acknowledged targeting last winter’s version of Omicron is …

COVID-19: Nasal vaccine's phase 3 trial completed, informs Bharat Biotech chief
2 years, 6 months ago

COVID-19: Nasal vaccine's phase 3 trial completed, informs Bharat Biotech chief

Firstpost  

Dr Krishna Ella said that the company will submit its data with Drugs Controller General of India next month and If everything is okay, it will be the world’s first clinically proven nasal COVID-19 vaccine Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday said that the clinical phase III trials of the COVID-19 nasal vaccine have …

New plant-based Covid vaccine 70% effective against variants: Study
2 years, 7 months ago

New plant-based Covid vaccine 70% effective against variants: Study

India Today  

A new plant-based Covid-19 vaccine is nearly 70 per cent effective against symptomatic disease caused by five variants of the coronavirus, according to results of the human clinical trial of the preventive. The study, published on Thursday in the New England Journal of Medicine, shows that the vaccine efficacy was 69.5 per cent against any symptomatic Covid-19 caused by five …

'New plant-based COVID-19 vaccine 70% effective against variants'
2 years, 7 months ago

'New plant-based COVID-19 vaccine 70% effective against variants'

Firstpost  

The vaccine developed by researchers at Canadian biotechnology company Medicago contains coronavirus-like particles produced in plants which are combined with an adjuvant that helps vaccines work better Toronto: A new plant-based COVID-19 vaccine is nearly 70 per cent effective against symptomatic disease caused by five variants of the coronavirus, according to results of the human clinical trial of the preventive. …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 7 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

EU regulator advises AstraZeneca’s COVID drug be cleared
2 years, 8 months ago

EU regulator advises AstraZeneca’s COVID drug be cleared

Associated Press  

LONDON — The European Union’s drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus. The agency said it had assessed data on the drug from more than 5,000 people and found Evusheld reduced the risk of infection by 77%, with protection estimated …

EU Drug Watchdog Approves AstraZeneca Covid Prevention Jab 'Evusheld'
2 years, 8 months ago

EU Drug Watchdog Approves AstraZeneca Covid Prevention Jab 'Evusheld'

News 18  

The EU’s drug watchdog on Thursday recommended for approval AstraZeneca’s Covid-19 prevention cocktail, which can be used for patients with immune system problems or severe reactions to other coronavirus vaccines. The European Medicines Agency’s human medicines committee “has recommended granting a marketing authorisation for Evusheld, developed by AstraZeneca for the prevention of Covid-19 in adults and adolescents from 12 years …

AstraZeneca set to abandon push for US vaccine approval
2 years, 9 months ago

AstraZeneca set to abandon push for US vaccine approval

The Telegraph  

AstraZeneca is braced to abandon efforts to get its Covid vaccine approved in the US if it is simply "banging its head against a brick wall indefinitely" with regulators. Speaking to the Financial Times, he said: “If we don’t end up submitting it for a BLA, I don’t think it will have an impact around the world.” The company has …

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies
2 years, 10 months ago

Very small blood clot risk after first AstraZeneca Covid shot, say UK studies

India Today  

A large study into rare blood clots linked with AstraZeneca's Covid-19 vaccine found between just one and three cases per million, and only after the first dose, shedding fresh light on the side-effects from the shot. Read: BA.2 sub-variant of Omicron spreads faster, but not more severe, says WHO A study published in the PLOS Medicine journal on Tuesday looked …

US to evaluate Covaxin as COVID-19 vaccine candidate, announces Bharat Biotech
2 years, 10 months ago

US to evaluate Covaxin as COVID-19 vaccine candidate, announces Bharat Biotech

Firstpost  

The FDA has lifted its clinical hold on Bharat Biotech’s Investigational New Drug application to evaluate the COVID-19 vaccine candidate, BBV152, known as Covaxin outside the United States Hyderabad: Hyderabad-based Bharat Biotech on Saturday said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States. “Ocugen, Inc announced that the US Food …

Critical AstraZeneca views ‘probably killed hundreds of thousands’ – scientist
2 years, 10 months ago

Critical AstraZeneca views ‘probably killed hundreds of thousands’ – scientist

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} An Oxford …

UK Marks First Anniversary of Oxford-AstraZeneca Covid-19 Vaccine Deployment
2 years, 11 months ago

UK Marks First Anniversary of Oxford-AstraZeneca Covid-19 Vaccine Deployment

News 18  

The UK's health service on Tuesday marked the first anniversary of the deployment of the Oxford/AstraZeneca vaccine against COVID-19, manufactured and deployed in India soon after as Covishield. "Backed by government funding, the UK-made Oxford-AstraZeneca vaccine has played an absolutely crucial role in our fight against COVID-19, saving countless lives in the UK and around the world," said UK Health …

EXPLAINED: It's Not Only The Novel Coronavirus That Can Keep Changing, Vaccines Could Too
2 years, 11 months ago

EXPLAINED: It's Not Only The Novel Coronavirus That Can Keep Changing, Vaccines Could Too

News 18  

It’s been little over a year since the first vaccines against Covid-19 were rolled out under emergency approvals. But given the suggestion that “it’s just a little naive to think that the vaccines that we made in the first few hot minutes of the pandemic are the best vaccines that we can make”, there’s focus now on coming up with …

As COVID's Omicron variant surges, do over 60s who got the AstraZeneca vaccine need a booster sooner?
3 years ago

As COVID's Omicron variant surges, do over 60s who got the AstraZeneca vaccine need a booster sooner?

ABC  

Linda Fisher and her husband Ken are members of Generation AZ: the group of those aged 60+ who lined up for an AstraZeneca vaccine, the only one available to their age group for some time. "If Omicron didn't exist you would probably feel pretty relaxed around Christmas this year," he says. "Most people have a certain degree of immunity which …

COVID: Study suggests AstraZeneca booster works against Omicron
3 years ago

COVID: Study suggests AstraZeneca booster works against Omicron

Al Jazeera  

Findings from the study, which has yet to be peer reviewed, match those from Pfizer-BioNTech and Moderna. AstraZeneca has said that a third dose of its COVID-19 vaccine “significantly” lifted antibody levels against the Omicron coronavirus variant, citing data from a new laboratory study. Boosters ‘limit Omicron spread’ Oxford’s researchers analysed blood samples taken from individuals infected with COVID-19; those …

Our vaccines may become ineffective, says COVID-19 task force chief as India battles Omicron
3 years ago

Our vaccines may become ineffective, says COVID-19 task force chief as India battles Omicron

Firstpost  

Dr VK Paul hoped that coronavirus in India is possibly moving in the direction of endemicity, where there is a low or moderate level of transmission going on New Delhi: Amid concerns over Omicron, India’s COVID Task Force chief VK Paul on Tuesday said there is a potential scenario that “our vaccines may become ineffective in emerging situations” and emphasised …

Mix and matching some COVID vaccines gives high immunity: Study
3 years ago

Mix and matching some COVID vaccines gives high immunity: Study

Al Jazeera  

Oxford University study finds mixing a first dose of the Pfizer or Astrazeneca vaccine with a second Moderna shot yields higher antibodies. “I think the data from this study will be especially interesting and valuable to low- and middle-income countries where they’re still rolling out the first two doses of vaccines,” Snape said. “We’re showing … you don’t have to …

SII Seeks Approval for Covishield Boosters: Is there Enough Data?
3 years ago

SII Seeks Approval for Covishield Boosters: Is there Enough Data?

The Quint  

While Serum Institute of India cited UK's MHRA giving the green light for AstraZeneca booster doses, they left out certain other key points. For one, around the same time, higher ups at AstraZeneca had warned against rushing into giving booster doses for all before 2 dose data is adequately studied. Expressing their reservations, Pascal Soriot, chief executive, and Sir Mene …

December 2, 2021 Omicron coronavirus variant news
3 years ago

December 2, 2021 Omicron coronavirus variant news

CNN  

Dr. Manjul Shukla transfers Pfizer COVID-19 vaccine into a syringe on Thursday, Dec. 2, 2021, at a mobile vaccination clinic in Worcester, Massachusetts. Any one of six different Covid-19 vaccines produce a strong immune system response and should work safely and well as boosters for people who have received initial vaccinations with either the Pfizer/BioNTech or AstraZeneca vaccines, British researchers …

December 2, 2021 Omicron coronavirus variant news
3 years ago

December 2, 2021 Omicron coronavirus variant news

CNN  

Dr. Manjul Shukla transfers Pfizer COVID-19 vaccine into a syringe on Thursday, Dec. 2, 2021, at a mobile vaccination clinic in Worcester, Massachusetts. Any one of six different Covid-19 vaccines produce a strong immune system response and should work safely and well as boosters for people who have received initial vaccinations with either the Pfizer/BioNTech or AstraZeneca vaccines, British researchers …

Covishield: Oxford-Astrazeneca vaccine remained effective even during India’s brutal second wave
3 years ago

Covishield: Oxford-Astrazeneca vaccine remained effective even during India’s brutal second wave

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy The Covishield vaccine was effective …

Omicron variant: Will the COVID-19 Pfizer, Moderna, AstraZeneca vaccines protect you?
3 years ago

Omicron variant: Will the COVID-19 Pfizer, Moderna, AstraZeneca vaccines protect you?

ABC  

The Omicron variant has been generating anxiety across the world since being declared a COVID-19 variant of concern by the World Health Organization over the weekend. According to Westmead Institute virologist Tony Cunningham, scientists around the world — including those in Australia — would be looking at whether protective antibodies in the vaccines were "sufficiently high" to cover this strain. …

After Alpha, beta, gamma and delta, world scurries to contain new COVID variant omicron
3 years ago

After Alpha, beta, gamma and delta, world scurries to contain new COVID variant omicron

Firstpost  

There was an increasing evidence that the variant is already spreading with cases being reported in travelers in Belgium, Israel and Hong Kong, and Germany also has a probable case The Hague: With each passing hour, new restrictions were being slapped on travel from countries in southern Africa as the world scurried Saturday to contain a new variant of the …

Discover Related